Characterization and risk assessment of host cell proteins using mass spectrometry

The purpose of this survey was to gather preliminary information from across the biopharmaceutical industry on the characterization and risk assessment of HCP using mass spectrometry. The results have allowed mapping of the process member companies use to identify and assess the safety risks presented by host cell proteins.

This document is reserved for the use of BioPhorum members only.

I don't have access to this document

Make a selection below and submit your request. We will get back to you ASAP.

My company would like to become a member

If you're not sure if your company is a member of this Phorum, or if you would like to enquire on behalf of your company about becoming a member, please see our membership page.